Pentobarbital Fails to Reduce Cerebral Oxygen Consumption Early after Non-Hemorrhagic Closed Head Injury in Rats

Journal of Neurotrauma

Volumn 22, Issue 7, 2005, Pages 793-806

  De Visscher, Geofrey ^a,b   Rooker, Servan ^c   Jorens, Philippe ^c   Verlooy, Jan ^c   Borgers, Marcel ^b   Reneman, Robert S ^b   Van Rossem, Koen ^d   Flameng, Willem ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

Barbiturate; CBF; CMRO2; Near infrared spectroscopy; Neurotrauma

Indexed keywords

CYTOCHROME C OXIDASE; OXYGEN; PENTOBARBITAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN METABOLISM; BRAIN MITOCHONDRION; BRAIN OXYGEN CONSUMPTION; BRAIN PERFUSION; CONTROLLED STUDY; HEAD INJURY; HEMODYNAMICS; MALE; METABOLIC RATE; NEAR INFRARED SPECTROSCOPY; NERVOUS SYSTEM INJURY; NONHUMAN; RAT; TREATMENT FAILURE;

ANIMALS; BRAIN INJURIES; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ELECTRON TRANSPORT COMPLEX IV; ENERGY METABOLISM; HEAD INJURIES, CLOSED; HYPNOTICS AND SEDATIVES; MALE; MITOCHONDRIA; OXYGEN CONSUMPTION; PENTOBARBITAL; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT FAILURE;

EID: 22244444805     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2005.22.793     Document Type: Article

References (42)

1. ARRIDGE, S.R., COPE, M., and DELPY, D.T. (1992). The theoretical basis for the determination of optical pathlengths in tissue: temporal and frequency analysis. Phys. Med. Biol. 37, 1531-1560.
2. BLAND, J.M., and ALTMAN, D.G. (1986). Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1, 307-310.
3. BOUMA, G.J., MUIZELAAR, J.P., CHOI, S.C., NEWLON, P.G., and YOUNG, H.F. (1991). Cerebral circulation and metabolism after severe traumatic brain injury: the elusive role of ischemia. J. Neurosurg. 75, 685-693.
4. BOUMA, G.J., MUIZELAAR, J.P., STRINGER, W.A., CHOI, S.C., FATOUROS, P., and YOUNG, H.F. (1992). Ultra-early evaluation of regional cerebral blood flow in severely head-injured patients using xenon-enhanced computerized tomography. J. Neurosurg. 77, 360-368.
5. Brain Trauma Foundation, American Association of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care. (1996). Guidelines for the management of severe head injury. J. Neurotrauma 13, 641-734.
6. Brain Trauma Foundation, American Association of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care. (2000). Use of barbiturates in the control of intracranial hypertension. J. Neurotrauma 17, 527-530.
7. COOPER, C.E., MATCHER, S.J., WYATT, J.S., et al. (1994). Near-infrared spectroscopy of the brain: relevance to cytochrome oxidase bioenergetics. Biochem. Soc. Trans. 22, 974-980.
8. COOPER, C.E., DELPY, D.T., and NEMOTO, E.M. (1998). The relationship of oxygen delivery to absolute haemoglobin oxygenation and mitochondrial cytochrome oxidase redox state in the adult brain: a near-infrared spectroscopy study. Biochem. J. 332, 627-632.
9. COPE, M., DELPY, D.T., WRAY, S., WYATT, J.S., and REYNOLDS, E.O. (1989). A CCD spectrophotometer to quantitate the concentration of chromophores in living tissue utilising the absorption peak of water at 975 nm. Adv. Exp. Med. Biol. 248, 33-40.
10. DE MULDER, G., VAN ROSSEM, K., VAN REEMPTS, J., BORGERS, M., and VERLOOY, J. (2000). Validation of a closed head injury model for use in long-term studies. Acta Neurochir. (Wien) Suppl. 76, 409-413.
11. DE VISSCHER, G., SPRINGETT, R., DELPY, D.T., VAN REEMPTS, J., BORGERS, M., and VAN ROSSEM, K. (2002a). Nitric oxide does not inhibit cerebral cytochrome oxidase in vivo or in the reactive hyperemic phase after brief anoxia in the adult rat. J. Cereb. Blood Flow Metab. 22, 515-519.
12. DE VISSCHER, G., VAN ROSSEM, K., VAN REEMPTS, J., BORGERS, M., FLAMENG, W., and RENEMAN, R.S. (2002b). Cerebral blood flow assessment with indocyanine green bolus transit detection by near-infrared spectroscopy in the rat. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 132, 87-95.
13. DE VISSCHER, G., LEUNENS, V., BORGERS, M., RENEMAN, R.S., FLAMENG, W., and VAN ROSSEM, K. (2003). NIRS mediated CBF assessment: validating the indocyanine green bolus transit detection by comparison with coloured microsphere flowmetry. Adv. Exp. Med. Biol. 540, 37-45.
14. EISENBERG, H.M., FRANKOWSKI, R.F., CONTANT, C.F., MARSHALL, L.F., and WALKER, M.D. (1988). High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury. J. Neurosurg. 69, 15-23.
15. ENGELBORGHS, K., VERLOOY, J., VAN DEUREN, B., VAN REEMPTS, J., and BORGERS, M. (1997). Intracranial pressure in a modified experimental model of closed head injury. Acta Neurochir. (Wien) Suppl. 70, 123-125.
16. HOFF, J.T., PITTS, L.H., SPETZLER, R., and WILSON, C.B. (1977). Barbiturates for protection from cerebral ischemia in aneurysm surgery. Acta Neurol. Scand. Suppl. 64, 158-159.
17. HYDER, F., KENNAN, R.P., KIDA, I., MASON, G.F., BEHAR, K.L., and ROTHMAN, D. (2000). Dependence of oxygen delivery on blood flow in rat brain: a 7-tesla nuclear magnetic resonance study. J. Cereb. Blood Flow Metab. 20, 485-498.
18. KASSELL, N.F., PEERLESS, S.J., DRAKE, G.G., BOARINI, D.J., and ADAMS, H.P. (1980). Treatment of ischemic deficits from cerebral vasospasm with high-dose barbiturate therapy. Neurosurgery 7, 593-597.
19. KUEBLER, W.M., SCKELL, A., HABLER, O., et al. (1998). Noninvasive measurement of regional cerebral blood flow by near-infrared spectroscopy and indocyanine green. J. Cereb. Blood Flow Metab. 18, 445-456.
20. LANDSMAN, M.L., KWANT, G., MOOK, G.A., and ZIJLSTRA, W.G. (1976). Light-absorbing properties, stability, and spectral stabilization of indocyanine green. J. Appl. Physiol. 40, 575-583.
21. LEE, M.W., DEPPE, S.A., SIPPERLY, M.E., BARRETTE, R.R., and THOMPSON, D.R. (1994). The efficacy of barbiturate coma in the management of uncontrolled intracranial hypertension following neurosurgical trauma. J. Neurotrauma 11, 325-331.
22. MARSHALL, L.F., SMITH, R.W., and SHAPIRO, H.M. (1979). The outcome with aggressive treatment in severe head injuries. Part II: acute and chronic barbiturate administration in the management of head injury. J. Neurosurg. 50, 26-30.
23. MATCHER, S.J., and COOPER, C.E. (1994). Absolute quantification of deoxyhaemoglobin concentration in tissue near infrared spectroscopy. Phys. Med. Biol. 39, 1295-1312.
24. MATCHER, S.J., ELWELL, C.E., COOPER, C.E., COPE, M., and DELPY, D.T. (1995). Performance comparison of several published tissue near-infrared spectroscopy algorithms. Anal. Biochem. 227, 54-68.
25. MILLER, J.D., BUTTERWORTH, J.F., GUDEMAN, S.K., et al. (1981). Further experience in the management of severe head injury. J. Neurosurg. 54, 289-299.
26. PAPPAS, T.N., and MIRONOVICH, R.O. (1981). Barbiturate-induced coma to protect against cerebral ischemia and increased intracranial pressure. Am. J Hosp. Pharm. 38, 494-498.
27. RENAULT, G., MUFFAT-JOLY, M., POLIANSKI, J., et al. (1987). NADH in situ laser fluorimetry: effect of pentobarbital on continuously monitored myocardial redox state. Lasers Surg. Med. 7, 339-346.
28. ROBERTS, I. (2000). Barbiturates for acute traumatic brain injury. Cochrane Database Syst. Rev. CD000033.
29. ROOKER, S., JORENS, P.G., VAN REEMPTS, J., BORGERS, M., and VERLOOY, J. (2003). Continuous measurement of intracranial pressure in awake rats after experimental closed head injury. J. Neurosci. Methods 131, 75-81.
30. SAPRU, H.N., and KRIEGER, A.J. (1979). Cardiovascular and respiratory effects of some anesthetics in the decerebrate rat. Eur. J. Pharmacol. 53, 151-158.
31. SCHWARTZ, M.L., TATOR, C.H., ROWED, D.W., REID, S.R., MEGURO, K., and ANDREWS, D.F. (1984). The University of Toronto head injury treatment study: a prospective, randomized comparison of pentobarbital and mannitol. Can. J Neurol. Sci. 11, 434-440.
32. SHAABAN, A.M., HARMER, M., and LATTO, I. (2001). Jugular bulb oximetry during cardiac surgery. Anaesthesia 56, 24-37.
33. SMITH, A.L. (1977). Barbiturate protection in cerebral hypoxia. Anesthesiology 47, 285-293.
34. SPRINGETT, R., NEWMAN, J., COPE, M., and DELPY, D.T. (2000). Oxygen dependency and precision of cytochrome oxidase signal from full spectral NIRS of the piglet brain. Am. J. Physiol Heart Circ. Physiol. 279, H2202-H2209.
35. STEEN, P.A. (1991). Barbiturates in neuroanesthesia and neuro-intensive care. Agressologic 32, 323-325.
36. THORNILEY, M.S., LANE, N.J., MANEK, S., and GREEN, CJ. (1994). Non-invasive measurement of respiratory chain dysfunction following hypothermic renal storage and transplantation. Kidney Int. 45, 1489-1496.
37. VAN ROSSEM, K., GARCIA-MARTINEZ, S., DE MULDER, G., et al. (1999a). Brain oxygenation after experimental closed head injury. A NIRS study. Adv. Exp. Med. Biol. 471, 209-215.
38. VAN ROSSEM, K., GARCIA-MARTINEZ, S, WOUTERS, L., et al. (1999b). Cytochrome oxidase redox state in brain is more sensitive to hypoxia after closed head injury: a near-infrared spectroscopy (NIRS) study. J. Cereb. Blood Flow Metab. 19, S391.
39. WARD, J.D., BECKER, D.P., MILLER, J.D., et al. (1985). Failure of prophylactic barbiturate coma in the treatment of severe head injury. J. Neurosurg. 62, 383-388.
40. WATZMAN, H.M., KURTH, C.D., MONTENEGRO, L.M., ROME, J., STEVEN, J.M., and NICOLSON, S.C. (2000). Arterial and venous contributions to near-infrared cerebral oximetry. Anesthesiology 93, 947-953.
41. WILSON, R.P., ZAGON, I.S., LARACH, D.R., and LANG, C.M. (1993). Cardiovascular and respiratory effects of tiletamine-zolazepam. Pharmacol. Biochem. Behav. 44, 1-8.
42. WIXSON, S.K., WHITE, WJ., HUGHES, H.C., JR., LANG, C.M., and MARSHALL, W.K. (1987). The effects of pentobarbital, fentanyl-droperidol, ketamine-xylazine and ketamine-diazepam on arterial blood pH, blood gases, mean arterial blood pressure and heart rate in adult male rats. Lab. Anim. Sci. 37, 736-742.